Teriflunomide: a novel oral treatment for relapsing multiple sclerosis

Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial

(2014) Christian Confavreux et al.   LANCET NEUROLOGY

The effects of teriflunomide on lymphocyte subpopulations in human peripheral blood mononuclear cells in vitro

(2013) Li Li et al.   JOURNAL OF NEUROIMMUNOLOGY

Teriflunomide reduces relapse-related neurological sequelae, hospitalizations and steroid use

(2013) Paul W. O’Connor et al.   JOURNAL OF NEUROLOGY

Siponimod for patients with relapsing-remitting multiple sclerosis (BOLD): an adaptive, dose-ranging, randomised, phase 2 study

(2013) Krzysztof Selmaj et al.   LANCET NEUROLOGY

The best clinical paper on multiple sclerosis in 2012

(2013) Aaron E Miller   Multiple Sclerosis Journal

Magnetic resonance imaging outcomes from a phase III trial of teriflunomide

(2013) Jerry S Wolinsky et al.   Multiple Sclerosis Journal

ECTRIMS 2013: Posters I

(2013)   Multiple Sclerosis Journal

Teriflunomide effect on immune response to influenza vaccine in patients with multiple sclerosis

(2013) A. Bar-Or et al.   NEUROLOGY

PML in a Patient Treated with Dimethyl Fumarate from a Compounding Pharmacy

(2013) Bob W. van Oosten et al.   NEW ENGLAND JOURNAL OF MEDICINE

PML in a Patient Treated with Fumaric Acid

(2013) Ummehan Ermis et al.   NEW ENGLAND JOURNAL OF MEDICINE

Pregnancy outcome in women exposed to leflunomide before or during pregnancy

(2012) M. Cassina et al.   ARTHRITIS AND RHEUMATISM

Pre-specified subgroup analyses of a placebo-controlled phase III trial (TEMSO) of oral teriflunomide in relapsing multiple sclerosis

(2012) Aaron E Miller et al.   Multiple Sclerosis Journal

Long-term follow-up of a phase 2 study of oral teriflunomide in relapsing multiple sclerosis: safety and efficacy results up to 8.5 years

(2012) Christian Confavreux et al.   Multiple Sclerosis Journal

Teriflunomide added to interferon-  in relapsing multiple sclerosis: A randomized phase II trial

(2012) M. S. Freedman et al.   NEUROLOGY

Fingolimod for Multiple Sclerosis

(2012) Daniel Pelletier et al.   NEW ENGLAND JOURNAL OF MEDICINE

Placebo-Controlled Trial of Oral Laquinimod for Multiple Sclerosis

(2012) Giancarlo Comi et al.   NEW ENGLAND JOURNAL OF MEDICINE

Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis

(2012) Robert J. Fox et al.   NEW ENGLAND JOURNAL OF MEDICINE

Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis

(2012) Ralf Gold et al.   NEW ENGLAND JOURNAL OF MEDICINE

Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria

(2011) Chris H. Polman et al.   ANNALS OF NEUROLOGY

Immune mechanisms of new therapeutic strategies in MS — Teriflunomide

(2011) Malte C. Claussen et al.   CLINICAL IMMUNOLOGY

Excitability out of balance: Treating hemineglect with transcranial magnetic brain stimulation

(2011) H. M. Schambra et al.   NEUROLOGY

Randomized Trial of Oral Teriflunomide for Relapsing Multiple Sclerosis

(2011) Paul O'Connor et al.   NEW ENGLAND JOURNAL OF MEDICINE

Birth outcomes in women who have taken leflunomide during pregnancy

(2010) Christina D. Chambers et al.   ARTHRITIS AND RHEUMATISM

Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis

(2010) Jeffrey A. Cohen et al.   NEW ENGLAND JOURNAL OF MEDICINE

Teriflunomide reduces behavioral, electrophysiological, and histopathological deficits in the Dark Agouti rat model of experimental autoimmune encephalomyelitis

(2009) Jean E. Merrill et al.   JOURNAL OF NEUROLOGY

Multiple sclerosis

(2008) Alastair Compston et al.   LANCET